
Presight Capital
Description
Presight Capital is a prominent venture capital firm based in West Hollywood, California, established in 2017. Co-founded by Christian Angermayer, Max Niederhofer, and Fabian Friede, the firm distinguishes itself by investing in ambitious founders across a broad spectrum of sectors, stages, and geographies. Their investment philosophy is deeply rooted in being "founder-first," aiming to be long-term partners for the companies they back. This broad mandate allows them to explore opportunities in diverse areas, including biotech, fintech, artificial intelligence, and consumer technologies.
The firm's strategic approach involves identifying and supporting disruptive innovations from their earliest stages, often serving as the first institutional investor or a significant early participant. Presight Capital demonstrated its substantial financial capacity and commitment to this strategy with the closing of its second fund, Presight Capital II, L.P., which successfully raised $350 million in 2021. This significant capital pool enables them to deploy substantial resources into promising startups.
Presight Capital typically deploys initial checks ranging from $500,000 to $10 million, showcasing their flexibility to engage with companies from seed stage through Series A and even into Series B. Beyond the initial investment, they retain the capacity to provide significant follow-on funding to support their portfolio companies' continued growth and development. Their portfolio spans a wide array of innovative companies, reflecting their sector-agnostic approach and commitment to fostering groundbreaking ventures globally.
Investor Profile
Presight Capital has backed more than 97 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 12% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Germany, United Kingdom.
- Strong thematic focus on Biotechnology, Financial Services, Health Care.
- Led 1 rounds in the past year.
- Typical check size: $500K – $10M.
Stage Focus
- Seed (33%)
- Series A (25%)
- Series B (15%)
- Series C (7%)
- Series Unknown (5%)
- Series D (4%)
- Convertible Note (3%)
- Debt Financing (2%)
- Pre Seed (2%)
- Post Ipo Equity (1%)
Country Focus
- United States (44%)
- Germany (13%)
- United Kingdom (7%)
- Singapore (6%)
- Canada (4%)
- United Arab Emirates (4%)
- India (4%)
- Switzerland (3%)
- Mexico (3%)
- Brazil (3%)
Industry Focus
- Biotechnology
- Financial Services
- Health Care
- E-commerce
- Fintech
- Life Science
- Therapeutics
- Retail
- Software
- Banking
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.